VERIGRAFT Advances First Potential Curative Treatment for CVI into Pivotal Phase II/III Trial
Pivotal Phase II/III clinical …
Pivotal Phase II/III clinical …
SHANGHAI, March 25, 2026 /PRNe…
LISHUI, China, March 25, 2026 …
HONG KONG, March 25, 2026 /PRN…
Pivotal Phase II/III clinical …
DHL Expressの「Delivering Dreams…
BANGKOK, Thailand, March 25, 2…